{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T18:44:17Z","timestamp":1755801857402,"version":"3.44.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.clml.2025.04.009","type":"journal-article","created":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T19:41:02Z","timestamp":1744918862000},"page":"e619-e627","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Role of a Multidisciplinary Program (Amyloidosis Program of Calgary) on Recognition and Intervention for AL and ATTR Amyloidosis"],"prefix":"10.1016","volume":"25","author":[{"given":"Aksha","family":"Burande","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nowell","family":"Fine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4676-2433","authenticated-orcid":false,"given":"Robert JH","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2386-8817","authenticated-orcid":false,"given":"Christopher","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Etienne","family":"Mahe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debra","family":"Bosley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lyndsay","family":"Litwin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9294-9437","authenticated-orcid":false,"given":"Victor H","family":"Jimenez-Zepeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.clml.2025.04.009_bib0001","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1002\/ajh.25819","article-title":"Immunoglobulin light chain amyloidosis: 2020 update on diagnosis, prognosis, and treatment","volume":"95","author":"Gertz","year":"2020","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1016\/j.clml.2025.04.009_bib0002","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1001\/jama.2020.5493","article-title":"Systemic amyloidosis recognition, prognosis, and therapy: a systematic review","volume":"324","author":"Gertz","year":"2020","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.clml.2025.04.009_bib0003","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1080\/13506129.2022.2147636","article-title":"Amyloid nomenclature 2022: update, novel proteins, and recommendations by the International Society of Amyloidosis (ISA) Nomenclature Committee","volume":"29","author":"Buxbaum","year":"2022","journal-title":"Amyloid"},{"key":"10.1016\/j.clml.2025.04.009_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2019.100636","article-title":"New developments in diagnosis, risk assessment and management in systemic amyloidosis","volume":"40","author":"Vaxman","year":"2020","journal-title":"Blood Rev"},{"issue":"1","key":"10.1016\/j.clml.2025.04.009_bib0005","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1182\/hematology.2020006913","article-title":"Management of AL amyloidosis in 2020","volume":"2020","author":"Palladini","year":"2020","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"Suppl 1","key":"10.1016\/j.clml.2025.04.009_bib0006","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.amjmed.2022.01.004","article-title":"When to suspect and how to approach a diagnosis of amyloidosis","volume":"135","author":"Law","year":"2022","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.clml.2025.04.009_bib0007","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13023-024-03052-w","article-title":"Needs of amyloidosis patients and their care providers: design & first results of the (A)MY-NEED(S) research and care program","volume":"19","author":"Ihne-Schubert","year":"2024","journal-title":"Orphanet J Rare Dis"},{"issue":"7","key":"10.1016\/j.clml.2025.04.009_bib0008","doi-asserted-by":"crossref","first-page":"370","DOI":"10.4330\/wjc.v16.i7.370","article-title":"Recent advances in the diagnostic methods and therapeutic strategies of transthyretin cardiac amyloidosis","volume":"16","author":"Kourek","year":"2024","journal-title":"World J Cardiol"},{"issue":"3","key":"10.1016\/j.clml.2025.04.009_bib0009","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.clml.2022.12.013","article-title":"A comprehensive multidisciplinary diagnostic algorithm for the early and efficient detection of amyloidosis","volume":"23","author":"Jimenez-Zepeda","year":"2023","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"24","key":"10.1016\/j.clml.2025.04.009_bib0010","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMra2304088","article-title":"Systemic light chain amyloidosis","volume":"390","author":"Sanchorawala","year":"2024","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.clml.2025.04.009_bib0011","first-page":"60","article-title":"Red flags of cardiac amyloidosis in patients with spinal stenosis and yellow ligament hypertrophy","volume":"162","author":"Negreira Caamano","year":"2024","journal-title":"Med Clin (Barc)"},{"issue":"3","key":"10.1016\/j.clml.2025.04.009_bib0012","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1080\/13506129.2023.2171787","article-title":"Factors affecting the accuracy of amyloidosis identification and referral to a specialty centre","volume":"30","author":"Staron","year":"2023","journal-title":"Amyloid"},{"key":"10.1016\/j.clml.2025.04.009_bib0013","doi-asserted-by":"crossref","first-page":"384","DOI":"10.18632\/oncotarget.28415","article-title":"Systemic AL amyloidosis: current approach and future direction","volume":"14","author":"Bou Zerdan","year":"2023","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.clml.2025.04.009_bib0014","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41408-024-01040-8","article-title":"Timing and co-occurrence of symptoms prior to a diagnosis of light chain (AL) amyloidosis","volume":"14","author":"Singh","year":"2024","journal-title":"Blood Cancer J"},{"issue":"11","key":"10.1016\/j.clml.2025.04.009_bib0015","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.jcmg.2023.07.007","article-title":"Cardiac amyloid quantification using (124)I-evuzamitide ((124)I-P5+14) versus (18)F-Florbetapir: a pilot PET\/CT study","volume":"16","author":"Clerc","year":"2023","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.clml.2025.04.009_bib0016","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.jcmg.2024.06.005","article-title":"Imaging in amyloidosis: 20 years of sustained innovation","volume":"11","author":"Fontana","year":"2024","journal-title":"JACC Cardiovasc Imaging"},{"issue":"6","key":"10.1016\/j.clml.2025.04.009_bib0017","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1007\/s12350-023-03297-1","article-title":"Diagnostic accuracy of bone scintigraphy imaging for transthyretin cardiac amyloidosis: systematic review and meta-analysis","volume":"30","author":"Ahluwalia","year":"2023","journal-title":"J Nucl Cardiol"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265025001405?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265025001405?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T03:16:32Z","timestamp":1755746192000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265025001405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":17,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S2152265025001405"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2025.04.009","relation":{},"ISSN":["2152-2650"],"issn-type":[{"type":"print","value":"2152-2650"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of a Multidisciplinary Program (Amyloidosis Program of Calgary) on Recognition and Intervention for AL and ATTR Amyloidosis","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2025.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}